Source: International Congress 2017 – Markers of COPD progression
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Jarenbäck (Gantofta, Sweden). Lung function reversibility as a predictor of disease progression in COPD. 1082

Member's Comments

No comment yet.

Related content which might interest you: Predictors of progression and risk of unfavorable outcome of chronic obstructive pulmonary disease Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system Year: 2015 Predictors of lung function deterioration in COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Prognosis: what is the contribution of inflammation to the decline in lung function in airway disease? Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007 Rate of progression of lung function impairment in α1-antitrypsin deficiency Source: Eur Respir J 2009; 33: 1338-1344 Year: 2009 Lung function indices versus symptoms for monitoring the course of the disease in patients with COPD Source: Annual Congress 2008 - Functionality and metabolism in rehabilitation candidates Year: 2008 Lung hyperinflation is a determinant of the heart rate recovery delay in COPD patients Source: International Congress 2017 – Evaluating lung function, dyspnoea and related respiratory diseases Year: 2017 Markers of early disease and prognosis in COPD Source: Annual Congress 2009 - Epidemiology of COPD Year: 2009 Bronchodilator response of advanced lung function parameters depending on COPD severity Source: International Congress 2016 – Functional assessment of the airways Year: 2016 Association of the neutrophil-to-lymphocyte ratio with lung function and exacerbations in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Systemic biomarkers Year: 2016 Which markers other than FEV1 reflect disease progression in COPD? Source: Eur Respir J 2004; 24: Suppl. 48, 45s Year: 2004 Lung volume response to bronchodilators is dependent on the stage of the disease in chronic obstructive pulmonary disease (COPD) patients Source: Annual Congress 2006 - COPD therapy Year: 2006 Chronic obstructive pulmonary disease as a predictor of lung cancer mortality Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Predictive factors of lung function in patients with COPD and heart failure Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020 Exercise desaturation in patients with COPD – potent  marker for more severe disease progression and prognosis Source: International Congress 2017 – Exercise testing in cardiorespiratory diseases Year: 2017 The influence of smoking on capnometry lung ventilation parameters in chronic obstructive pulmonary disease patients Source: International Congress 2015 – Molecular pathways of lung injury due to tobacco-related products Year: 2015 The impact of chronic obstructive pulmonary disease on survival of the patients with small-cell lung cancer Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 The relationship between bronchial inflammation and markers of disease progression in COPD Source: Eur Respir J 2003; 22: Suppl. 45, 179s Year: 2003 Relationship between lung function impairment and incidence or recurrence of cardiovascular disease in a middle-aged cohort Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD Year: 2007 Insulin resistance, lung function and exacerbation rate in chronic obstructive lung disease Source: International Congress 2015 – Monitoring airway diseases with lung function tests Year: 2015 Assessment the dependence between nutritional status and functional damage of the lungs as well as prognosis in BODE index in COPD patients Source: Annual Congress 2013 –COPD treatment Year: 2013